| Product NDC: | 25010-305 |
| Proprietary Name: | Demser |
| Non Proprietary Name: | metyrosine |
| Active Ingredient(s): | 250 mg/1 & nbsp; metyrosine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25010-305 |
| Labeler Name: | Aton Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017871 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19791003 |
| Package NDC: | 25010-305-15 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (25010-305-15) |
| NDC Code | 25010-305-15 |
| Proprietary Name | Demser |
| Package Description | 100 CAPSULE in 1 BOTTLE (25010-305-15) |
| Product NDC | 25010-305 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | metyrosine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19791003 |
| Marketing Category Name | NDA |
| Labeler Name | Aton Pharma, Inc. |
| Substance Name | METYROSINE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Catecholamine Synthesis Inhibitor [EPC],Catecholamine Synthesis Inhibitors [MoA] |